市場調査レポート

商品コード

陰圧創傷治療（NPWT）の世界市場の評価：製品タイプ別、創傷タイプ別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Negative Pressure Wound Therapy Market Assessment, By Product Type, By Wound Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年01月29日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 252 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の陰圧創傷治療（NPWT）の市場規模は、2023年に23億1,000万米ドル、2031年に34億9,000万米ドルに達し、2023年～2031年の予測期間にCAGRで5.28%の成長が見込まれています。陰圧創傷治療（NPWT）市場は、世界の先進創傷治療管理市場の中で急成長しているセグメントです。この市場の促進要因は、糖尿病とそれに伴う足潰瘍の有病率の増加、NPWTの技術の進歩や技術革新の進行、潰瘍創傷、手術創傷、熱傷を含む創傷症例の増加、陰圧創傷治療に対する需要の高まりなどです。糖尿病性足潰瘍は糖尿病患者の大きな懸念事項であり、糖尿病の流行とともに糖尿病性足潰瘍患者は増加しており、NPWTの需要をさらに促進しています。陰圧創傷治療は、創傷を短時間で管理し治療する上で非常に効果的であることが証明されており、NPWT市場の需要をさらに押し上げています。

さらに、外科手術の増加や交通事故の増加により、創傷治療を必要とする患者が増加しており、世界の陰圧創傷治療（NPWT）市場の成長をさらに促進しています。しかし、NPWTの実施に必要な熟練した専門家や技術的専門知識の不足、機器の高いコストなどが市場の抑制要因となっています。

例えば、2023年8月、医療用真空機器を専門とするスイス企業Medela AGは、「Invia Integrated Dressing」と名付けられた新しい一体型ドレッシング製品で陰圧創傷治療ポートフォリオを拡大すると発表しました。このドレッシングは2023年7月にFDAの承認を受け、MedelaのNPWTポンプ、Liberty、Motionと組み合わせられるに設計されています。この一体型ドレッシングは「貼ってはがせる」粘着剤で、皮膚に優しいシリコン粘着剤の縁取りとクイックコネクターを含む3層の流体処理パッドを持ち、取り扱いが容易です。

糖尿病とそれに伴う足潰瘍の有病率の増加

糖尿病とそれに伴う足潰瘍の有病率の増加は、陰圧創傷治療（NPWT）市場を大きく牽引しています。糖尿病は生活習慣病の1つであり、いくつかの合併症を伴いますが、糖尿病の主な合併症の1つに足潰瘍があります。糖尿病性足潰瘍（DFU）は、長年の糖尿病と管理不十分による一般的で非常に病的な結果であり、糖尿病患者の約19～34％が生涯に罹患すると推定されています。NPWTは糖尿病患者の糖尿病性足潰瘍を管理するための効果的でコスト効率の高い方法です。陰圧創傷治療が糖尿病性足潰瘍の効率的な創傷治癒を促進することは、いくつかの調査でも裏付けられています。例えば、2023年9月にNatureに掲載された調査によると、PRDX2（ペルオキシレドキシン2）は抗酸化作用を通じてNHDFの増殖と移動を促進します。また、これは糖尿病性足潰瘍のような慢性創傷の治療における陰圧創傷療法のメカニズムとして提唱されています。

陰圧創傷治療（NPWT）における技術の進歩の高まり

陰圧創傷治療における技術の進歩や技術革新の拡大は、市場にプラスの影響を与えます。圧力設定範囲の最適化、ドレッシングの粘着性の改善、治療で使用されるドレッシングの湿度管理などの技術革新がNPWTの使用と需要を促進し、市場の成長をさらに促進する可能性が高いです。技術の進歩により、NPWT機器はより効果的で使いやすく、価格も手頃なものとなり、病院と在宅医療の両方で採用が進んでいます。市場参入企業は、革新的なソリューションを通じて成長を強化する機会を活用しようとしています。

例えば2023年4月、3Mは、創傷から感染性物質、非生存組織、創傷残屑を水圧機械的に除去するVeraflo Cleanse Choice Complete DressingとVeraflo Cleanse Choice DressingのFDA承認を取得したと発表しました。これは肉芽形成を向上し、創傷治癒プロセスを速めます。3Mの陰圧創傷治療製品を含むVeraflowポートフォリオに加え、これらのドレッシング材も極めて重大です。

当レポートでは、世界の陰圧創傷治療（NPWT）市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。

市場規模と予測
- 金額
- 数量
製品タイプ別
- 使い捨てNPWT
- 従来のNPWT
- 付属品と、消耗品
創傷タイプ別
- 外傷
- 圧迫創傷
- 糖尿病性足潰瘍
- 火傷、手術創傷
- その他
エンドユーザー別
- 病院
- 診療所
- 在宅ケア環境
- その他
地域別
- 北米
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
市場シェア：企業別（2023年）

第5章世界の陰圧創傷治療市場の見通し（2017年～2031年）

北米
- 市場規模と予測
- 製品タイプ別
- 創傷タイプ別
- エンドユーザー別
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- イタリア
- 英国
- ロシア
- オランダ
- スペイン
- トルコ
- ポーランド
南米
- ブラジル
- アルゼンチン
アジア太平洋
- インド
- 中国
- 日本
- オーストラリア
- ベトナム
- 韓国
- インドネシア
- フィリピン
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ

第6章市場マッピング（2023年）

製品タイプ別
創傷タイプ別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需給分析
輸出入の分析 - 数量と金額
サプライ/バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因（課題、抑制要因）

第9章規制枠組みとイノベーション

臨床試験
特許情勢
規制当局の承認
イノベーション/新技術

第10章主要企業情勢

マーケットリーダー上位5社の競合マトリクス
マーケットリーダー上位5社の市場収益分析（2023年）
合併と買収/合弁事業（該当する場合）
SWOT分析（市場参入企業5社）
特許分析（該当する場合）

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

Smith & Nephew plc
3M Company
Molnlycke Health Care AB
Cardinal Health, Inc.
ConvaTec Group Plc
Paul Hartmann AG
DeRoyal Industries, Inc.
Lohmann & Rauscher International GmbH & Co KG
Medela AG
Genadyne Biotechnologies Inc.

第14章戦略的推奨事項

第15章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 3. Global Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 4. Global Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 5. Global Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 6. Global Negative Pressure Wound Therapy Market Share (%), By Region, 2017-2031F
Figure 7. North America Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 9. North America Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 10. North America Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 11. North America Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 12. North America Negative Pressure Wound Therapy Market Share (%), By Country, 2017-2031F
Figure 13. United States Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 15. United States Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 16. United States Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 17. United States Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 18. Canada Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 20. Canada Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 21. Canada Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 22. Canada Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 23. Mexico Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 25. Mexico Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 26. Mexico Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 27. Mexico Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 28. Europe Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 30. Europe Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 31. Europe Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 32. Europe Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Negative Pressure Wound Therapy Market Share (%), By Country, 2017-2031F
Figure 34. Germany Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 36. Germany Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 37. Germany Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 38. Germany Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 39. France Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 41. France Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 42. France Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 43. France Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 44. Italy Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 46. Italy Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 47. Italy Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 48. Italy Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 49. United Kingdom Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 51. United Kingdom Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 52. United Kingdom Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 53. United Kingdom Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 54. Russia Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 56. Russia Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 57. Russia Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 58. Russia Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 59. Netherlands Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 61. Netherlands Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 62. Netherlands Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 63. Netherlands Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 64. Spain Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 66. Spain Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 67. Spain Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 68. Spain Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 69. Turkey Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 71. Turkey Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 72. Turkey Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 73. Turkey Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 74. Poland Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 76. Poland Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 77. Poland Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 78. Poland Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 79. South America Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 81. South America Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 82. South America Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 83. South America Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 84. South America Negative Pressure Wound Therapy Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 87. Brazil Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 88. Brazil Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 89. Brazil Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 90. Argentina Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 92. Argentina Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 93. Argentina Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 94. Argentina Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 95. Asia-Pacific Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 97. Asia-Pacific Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 98. Asia-Pacific Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 99. Asia-Pacific Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 100. Asia-Pacific Negative Pressure Wound Therapy Market Share (%), By Country, 2017-2031F
Figure 101. India Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 103. India Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 104. India Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 105. India Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 106. China Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 108. China Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 109. China Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 110. China Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 111. Japan Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 113. Japan Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 114. Japan Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 115. Japan Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 116. Australia Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 118. Australia Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 119. Australia Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 120. Australia Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 121. Vietnam Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 123. Vietnam Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 124. Vietnam Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 125. Vietnam Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 126. South Korea Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 128. South Korea Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 129. South Korea Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 130. South Korea Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 131. Indonesia Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 133. Indonesia Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 134. Indonesia Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 135. Indonesia Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 136. Philippines Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 138. Philippines Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 139. Philippines Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 140. Philippines Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 141. Middle East & Africa Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 143. Middle East & Africa Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 144. Middle East & Africa Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 145. Middle East & Africa Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 146. Middle East & Africa Negative Pressure Wound Therapy Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 149. Saudi Arabia Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 150. Saudi Arabia Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 151. Saudi Arabia Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 152. UAE Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 154. UAE Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 155. UAE Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 156. UAE Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 157. South Africa Negative Pressure Wound Therapy Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Negative Pressure Wound Therapy Market, By Volume, in Thousand Units, 2017-2031F
Figure 159. South Africa Negative Pressure Wound Therapy Market Share (%), By Product Type, 2017-2031F
Figure 160. South Africa Negative Pressure Wound Therapy Market Share (%), By Wound Type, 2017-2031F
Figure 161. South Africa Negative Pressure Wound Therapy Market Share (%), By End-user, 2017-2031F
Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Wound Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX10878

Global negative pressure wound therapy (NPWT) market size was valued at USD 2.31 billion in 2023, and is expected to reach USD 3.49 billion in 2031, with a CAGR of 5.28% for the forecast period between 2023 and 2031F. The negative pressure wound therapy (NPWT) market is a fast-growing segment within the global advanced wound care management market. The market is driven by several factors, including the increasing prevalence of diabetes and associated foot ulcers, growing technological advancements and innovations in NPWT, growing cases of wounds including ulcers wounds, surgical and burn wounds, and growing demand for negative pressure wound therapies. Diabetes foot ulcer is a major concern for diabetic patients and with the increasing prevalence of diabetes, the diabetic foot ulcers patients are increasing, further driving the demand for NPWT. Negative pressure wound therapies have proven highly effective in managing and curing wounds in less time, further driving demand in the NPWT market.

Additionally, a growing number of surgical procedures and increasing cases of road accidents are leading to an increasing number of patients requiring wound care, further fueling the market growth for the global negative pressure wound therapy (NPWT) market. However, the lack of skilled professionals and technical expertise required for providing NPWT and the high cost of equipment are some of the restraints for the market.

For instance, in August 2023, Medela AG, a Swiss company specializing in medical vacuum devices, announced the expansion of its negative pressure wound therapy portfolio with a new integrated dressing product named 'Invia Integrated Dressing'. The dressing received FDA approval in July 2023 and is designed to work well with Medela NPWT pumps, Liberty, and MotionTM. The integrated dressing is a 'peel-and-stick' adhesive, having a three-layer fluid handling pad that contains a skin-friendly silicone adhesive border with a quick-connector for easy handling.

Growing Prevalence of Diabetes and Associated Foot Ulcers

The growing prevalence of diabetes and associated foot ulcers significantly drives the negative pressure wound therapy (NPWT) market. Diabetes, being a lifestyle disorder, comes with several comorbidities, one of the major complications in diabetes is foot ulcers. Diabetic foot ulcers (DFU) are a common, highly morbid consequence of longstanding and poorly managed diabetes and are estimated to affect about 19-34% of diabetes patients in their lifetime. NPWT is an effective and cost-efficient method for managing diabetic foot ulcers in diabetic patients. Several research supports the fact that negative pressure wound therapy promotes efficient wound healing in diabetic foot ulcers. For instance, according to research published in Nature, in September 2023, PRDX2 (Peroxiredoxin 2) promotes NHDF proliferation and migration through its antioxidant properties, which is the proposed mechanism of negative pressure wound therapies for the treatment of chronic wounds like diabetic foot ulcers.

Growing Technological Advancements in Negative Pressure Wound Therapy (NPWT)

Growing technological advancements and innovations in negative pressure wound therapy positively impact the market. Several innovations like optimization of range of pressure settings, improved adhesive nature of dressing, and humidity management of dressings used in therapies are likely to promote the use and demand of NPWT, further fueling the market growth. Technological advancements make NPWT devices more effective, user-friendly, and affordable, thereby driving their adoption in both hospitals and home healthcare settings. Market players are dedicated to harnessing the opportunity to enhance their growth in the market through innovative solutions.

For instance, in April 2023, 3M announced that it received FDA approval for Veraflo Cleanse Choice Complete Dressing and Veraflo Cleanse Choice Dressing for hydromechanical removal of infectious materials, non-viable tissues, and wound debris from wounds, thus reducing the number of surgical debridement required. It will improve the granulation formation and speed up the wound healing process. These dressings are crucial in addition to 3M's Veraflow portfolio containing negative pressure wound therapy products.

Conventional NPWT Segment is Expected to Dominate During Forecast Period

Conventional negative pressure wound therapies include reusable components thus minimizing the wastage and saving resources. The segment is expected to gain traction from healthcare professionals and hospitals as the vacuum devices can be reused and dressing needs to be changed, thus saving effort and resources for repeated purchase. It provides better management of exudates from severe wounds, improving the wound-healing process. Despite the popularity of conventional NPWT, single-use negative pressure wound therapy segment is expected to grow faster owing to post-pandemic alertness.

North America is Expected to Dominate the Market

With high investment in research and development activities, technological advancements by key players, and highly advanced healthcare infrastructure in North American countries like the United States and Canada, the region is expected to dominate the market with the highest value share. The supportive government initiatives for managing blood-related diseases are driving the growth of the market in the region. The high prevalence of diabetes and associated diabetic foot ulcers and other types of pressure ulcers in the region is contributing to the dominance of North America in the global negative pressure wound therapy market.

Key Players Landscape and Outlook

Market players are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products. To gain market share, companies are expanding the range of products they offer. Industry participants use a variety of growth methods, including collaborations, mergers and acquisitions, product launches, and the development of new goods, to bolster their positions in the market.

In May 2023, Smith & Nephew plc announced that its PICO single-use negative pressure wound therapy systems have received an Innovative Technology contract from Vizient, Inc. The contract was given to Smith & Nephew plc, based on the recommendation of hospital experts who serve on one of Vizient's member-led councils. Innovative Technology program aims to improve clinical care and enhance the business model for health care organizations with potential products recommended by healthcare professionals.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Negative Pressure Wound Therapy Market Outlook, 2017-2031F

4.1. Market Size and Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product Type
- 4.2.1. Single-Use NPWT
- 4.2.2. Conventional NPWT
- 4.2.3. Accessories and Consumables
4.3. By Wound Type
- 4.3.1. Traumatic Wounds
- 4.3.2. Pressure Injuries
- 4.3.3. Diabetic Foot Ulcers
- 4.3.4. Burns and Surgical Wounds
- 4.3.5. Others
4.4. By End-user
- 4.4.1. Hospitals
- 4.4.2. Clinics
- 4.4.3. Homecare Settings
- 4.4.4. Others
4.5. By Region
- 4.5.1. North America
- 4.5.2. Europe
- 4.5.3. Asia Pacific
- 4.5.4. South America
- 4.5.5. Middle East & Africa
4.6. By Company Market Share (%), 2023

5. Global Negative Pressure Wound Therapy Market Outlook, 2017-2031F

5.1. North America
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product Type
  - 5.1.2.1. Single-Use NPWT
  - 5.1.2.2. Conventional NPWT
  - 5.1.2.3. Accessories and Consumables
- 5.1.3. By Wound Type
  - 5.1.3.1. Traumatic Wounds
  - 5.1.3.2. Pressure Injuries
  - 5.1.3.3. Diabetic Foot Ulcers
  - 5.1.3.4. Burns and Surgical Wounds
  - 5.1.3.5. Others
- 5.1.4. By End-user
  - 5.1.4.1. Hospitals
  - 5.1.4.2. Clinics
  - 5.1.4.3. Homecare Settings
  - 5.1.4.4. Others
- 5.1.5. United States*
  - 5.1.5.1. Market Size & Forecast
  - 5.1.5.1.1. By Value
  - 5.1.5.1.2. By Volume
  - 5.1.5.2. By Product Type
  - 5.1.5.2.1. Single-Use NPWT
  - 5.1.5.2.2. Conventional NPWT
  - 5.1.5.2.3. Accessories and Consumables
  - 5.1.5.3. By Wound Type
  - 5.1.5.3.1. Traumatic Wounds
  - 5.1.5.3.2. Pressure Injuries
  - 5.1.5.3.3. Diabetic Foot Ulcers
  - 5.1.5.3.4. Burns and Surgical Wounds
  - 5.1.5.3.5. Others
  - 5.1.5.4. By End-user
  - 5.1.5.4.1. Hospitals
  - 5.1.5.4.2. Clinics
  - 5.1.5.4.3. Homecare Settings
  - 5.1.5.4.4. Others
- 5.1.6. Canada
- 5.1.7. Mexico

All segments will be provided for all regions and countries covered:

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. South America
- 5.3.1. Brazil
- 5.3.2. Argentina
5.4. Asia-Pacific
- 5.4.1. India
- 5.4.2. China
- 5.4.3. Japan
- 5.4.4. Australia
- 5.4.5. Vietnam
- 5.4.6. South Korea
- 5.4.7. Indonesia
- 5.4.8. Philippines
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product Type
6.2. By Wound Type
6.3. By End-user
6.4. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis - Volume and Value
7.3. Supply/Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Smith & Nephew plc
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. 3M Company
13.3. Molnlycke Health Care AB
13.4. Cardinal Health, Inc.
13.5. ConvaTec Group Plc
13.6. Paul Hartmann AG
13.7. DeRoyal Industries, Inc.
13.8. Lohmann & Rauscher International GmbH & Co KG
13.9. Medela AG
13.10. Genadyne Biotechnologies Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

陰圧創傷治療（NPWT）の世界市場の評価：製品タイプ別、創傷タイプ別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Negative Pressure Wound Therapy Market Assessment, By Product Type, By Wound Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

糖尿病とそれに伴う足潰瘍の有病率の増加

陰圧創傷治療（NPWT）における技術の進歩の高まり

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の陰圧創傷治療市場の見通し（2017年～2031年）

第5章 世界の陰圧創傷治療市場の見通し（2017年～2031年）

第6章 市場マッピング（2023年）

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要企業情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的推奨事項

第15章 当社について、免責事項